NasdaqCM - Nasdaq Real Time Price USD
Equillium, Inc. (EQ)
As of 9:37 AM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-15,643.0000
-21,783.0000
-8,733.0000
-32,081.0000
-24,624.0000
Investing Cash Flow
1,237.0000
-4,762.0000
18,684.0000
27,406.0000
-18,592.0000
Financing Cash Flow
-90.0000
-9,228.0000
-1,215.0000
31,061.0000
53,945.0000
End Cash Position
11,128.0000
23,216.0000
59,107.0000
50,366.0000
23,982.0000
Income Tax Paid Supplemental Data
--
580.0000
--
--
--
Interest Paid Supplemental Data
--
946.0000
847.0000
836.0000
839.0000
Capital Expenditure
--
-50.0000
-279.0000
-57.0000
-202.0000
Issuance of Capital Stock
--
--
--
29,909.0000
53,782.0000
Repayment of Debt
--
-9,133.0000
-1,429.0000
--
--
Repurchase of Capital Stock
--
-260.0000
--
--
--
Free Cash Flow
-15,774.0000
-21,833.0000
-9,012.0000
-32,138.0000
-24,826.0000
12/31/2020 - 10/12/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MTNB Matinas BioPharma Holdings, Inc.
0.6750
+21.62%
EYEN Eyenovia, Inc.
0.4958
+1.89%
LYRA Lyra Therapeutics, Inc.
0.2677
+1.03%
BRTX BioRestorative Therapies, Inc.
1.5999
-0.01%
GRI GRI Bio, Inc.
0.8600
-1.78%
RGLS Regulus Therapeutics Inc.
1.5000
+1.36%
SPRO Spero Therapeutics, Inc.
1.2987
-0.86%
MRNS Marinus Pharmaceuticals, Inc.
0.3500
-2.51%
NRBO NeuroBo Pharmaceuticals, Inc.
2.7500
+2.58%
TPST Tempest Therapeutics, Inc.
1.0550
-0.47%